"phase iii clinical field trials" , page-11

Its been really interesting reading everyones personal take on the EMS story from conspiracy stories (which I totally believe have a fair bit of logic with them, knowing DS is very disgruntled and sour about events which have taken place and no doubt will eventuate in the near future), to estimated price targets in the future.

My take = Provided Test results are in line with all our hopes, I agree with Big Dogs initial valuation of around 20 - 30c.

Then when the PR is done right, the media will be all over it like a rash - Perth based company with the most effective malaria treatment globally at present = MASSIVE story.

The new market cap will lead to a completely a new pool of investors ie fundy's.

The new found credibility from the success of the trials and the first successful project this company has EVER completed after all the failed ventures in the past, will generate huge interest and faith in the eagerly awaited Nicosorb project.

My estimate 70c - $1.50 first malaria deal announced
$4 - $10 Post Nicosorb and Pain Management.

Good luck to all long suffering loyal holders - the time is near!!